• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeImpact FactorAn 18-gene signature (ColoPrint) for colon cancer prognosis

An 18-gene signature (ColoPrint) for colon cancer prognosis

Iain Tan and Patrick Tan

1 May 2011 Impact Factor 0

Number 42

Download pdf article

ColoPrint is an 18-gene expression signature designed to predict disease relapse in patients with early-stage colorectal cancer (CRC). We discuss the potential impact of ColoPrint on clinical practice, and its contribution to our knowledge of CRC molecular heterogeneity.

Download full article

  • Agendia
  • colon cancer
  • ColoPrint
Previous article
Next article

Related Articles

News

Adjuvant therapy in stage III colon cancer: is less (really) better?

News 26 November 2018 0
No Picture
Senza categoria

Newsround

Senza categoria 1 May 2009 0
No Picture
Senza categoria

NEWSROUND

Senza categoria 1 July 2006 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy